Biomed Industrie, Inc. logo NA-931 for weight loss Biomed pipeline Biomed Industries, Inc. Engages with Medicare to Advan ...

A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with metabolic syndrome ... with discontinuation rates higher for those without ...

“Clinical trials of semaglutide and tirzepatide show that the average patient regains two-thirds of the weight lost (and similar changes in cardiometabolic variables) within the first year of ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

or multiple endocrine neoplasia syndrome type 2 (MEN2) — both extremely rare types of thyroid tumors — your medical provider will probably encourage you to avoid using semaglutide medications.

Semaglutide could help people drink less alcohol. Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was originally approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes (T2D). Current ...

It’s possible to experience significant, disruptive side effects while taking semaglutide for weight loss. Clinical trials have reported discontinuation rates (people quitting the medication ...

Coming off SSRIs can indeed be difficult, causing “SSRI discontinuation syndrome” in some people. The syndrome is characterised by flu-like symptoms, including dizziness, nausea, headaches and ...

You should inject semaglutide subcutaneously, that is, just under the surface of your skin. You can rotate injections between your stomach, upper arm, and thigh. Semaglutide is a prescription type ...